GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI International Medical Inc (NAS:BIMI) » Definitions » ROE %

BIMI International Medical (BIMI International Medical) ROE % : -127.75% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is BIMI International Medical ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BIMI International Medical's annualized net income for the quarter that ended in Sep. 2023 was $-12.52 Mil. BIMI International Medical's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $9.80 Mil. Therefore, BIMI International Medical's annualized ROE % for the quarter that ended in Sep. 2023 was -127.75%.

The historical rank and industry rank for BIMI International Medical's ROE % or its related term are showing as below:

BIMI' s ROE % Range Over the Past 10 Years
Min: -293.85   Med: -11.05   Max: -0.58
Current: -148.42

During the past 13 years, BIMI International Medical's highest ROE % was -0.58%. The lowest was -293.85%. And the median was -11.05%.

BIMI's ROE % is ranked worse than
93.42% of 608 companies
in the Healthcare Providers & Services industry
Industry Median: 4.32 vs BIMI: -148.42

BIMI International Medical ROE % Historical Data

The historical data trend for BIMI International Medical's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI International Medical ROE % Chart

BIMI International Medical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -89.81 -47.18 -15.73 -250.77 -293.85

BIMI International Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -129.71 -533.01 -60.69 45.60 -127.75

Competitive Comparison of BIMI International Medical's ROE %

For the Pharmaceutical Retailers subindustry, BIMI International Medical's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI International Medical's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI International Medical's ROE % distribution charts can be found below:

* The bar in red indicates where BIMI International Medical's ROE % falls into.



BIMI International Medical ROE % Calculation

BIMI International Medical's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=-22.393/( (11.193+4.048)/ 2 )
=-22.393/7.6205
=-293.85 %

BIMI International Medical's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-12.516/( (10.887+8.707)/ 2 )
=-12.516/9.797
=-127.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


BIMI International Medical  (NAS:BIMI) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-12.516/9.797
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-12.516 / 10.092)*(10.092 / 35.8495)*(35.8495 / 9.797)
=Net Margin %*Asset Turnover*Equity Multiplier
=-124.02 %*0.2815*3.6592
=ROA %*Equity Multiplier
=-34.91 %*3.6592
=-127.75 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-12.516/9.797
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-12.516 / -12.536) * (-12.536 / -12.6) * (-12.6 / 10.092) * (10.092 / 35.8495) * (35.8495 / 9.797)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9984 * 0.9949 * -124.85 % * 0.2815 * 3.6592
=-127.75 %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BIMI International Medical ROE % Related Terms

Thank you for viewing the detailed overview of BIMI International Medical's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI International Medical (BIMI International Medical) Business Description

Traded in Other Exchanges
N/A
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.
Executives
Ang Sammi Ean Seok director 2658 VISTA MONTE CIRCLE, CHINO HILLS CA 91709
Fnu Oudom director 7700 IRVINE CENTRE DRIVE, SUITE 800, IRVINE CA 92618
Xiaoping Wang director ROOM 4-6,NO.88-4 HUAYAN FIRST VILLAGE, SHAPINGBA DISTRICT, CHONGQING F4 400037
Baiqun Zhong officer: CFO 1-7, NO.27, HUAYAN NEW VILLAGE, JIULONGPO DISTRICT, CHONGQING F4 400039
Zhang Tingting director, officer: Chief Financial Officer 3708, FULI CENTER, NO.6 GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Song Tiewei director 17 FLOOR, FULI CENTER NO.6,GANGXING ROOD, ZHANGSHANG DISTRICT, DALIAN, LIAONING F4 116001
Yongquan Bi 10 percent owner ROOM 3708, WANDA PLACE, 6 GANGWAN ROAD, ZHONGSHAN DISTRICT, DALIAN CITY, LIAONING PROVINCE F4 116001
Wang Lihua director, 10 percent owner, officer: Chief Financial Officer NO 4 4 12 58 BAJING ROAD, HEPING DISTRICT SHENYANG CITY, LIAONING PROVINCW F4 110003
Li Gang director, 10 percent owner, officer: President and CEO 19B3 62 WEST HINHE ROAD, SHENHE DISTRICT SHENYANG CITY, LIAONING PROVINCE F4 110000
Jiuding Yan director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Lesley Jin director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Maclean John Coleman director 112 E 4TH AVE, SUITE 206, OLYMPIA WA 98501
Zhongmin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, SHENYANG F4 110021
Jianxin Wang director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021
Mia Kuang Ching director C/O NF ENERGY SAVING CORPORATION, 21 - JIA BEI SI DONG ROAD, TIE XI QU, SHENYANG F4 110021

BIMI International Medical (BIMI International Medical) Headlines

From GuruFocus

BIMI Announces Entry into a Material Definitive Agreement

By Value_Insider Value_Insider 12-13-2022

BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors

By GuruFocusNews GuruFocusNews 06-21-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 07-10-2022

BIMI Announces Sale of $2 Million Promissory Note

By Value_Insider Value_Insider 12-08-2022

BIMI Announces Entering into a $5 million Stock Purchase Agreement

By GuruFocusNews GuruFocusNews 06-10-2022

BIMI Enters into Definitive Agreement to Acquire Phenix Bio Inc.

By GuruFocusNews GuruFocusNews 07-07-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 06-07-2022

BIMI Announces Appointment of New Chairman and Independent Director

By GuruFocusNews GuruFocusNews 06-27-2022